Undiagnosed diabetes in the over-60s: Performance of the Association of Public Health Observatories (APHO) Diabetes Prevalence Model in a general practice

Diabetic Medicine

Volumn 29, Issue 1, 2012, Pages 115-120

  Hayes, L ^a   Hawthorne, G ^b   Unwin, N ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Newcastle Diabetes Centre   (United Kingdom)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Diabetes; Elderly; Primary care; Screening

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE;

AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GENERAL PRACTICE; GLUCOSE TOLERANCE TEST; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PUBLIC HEALTH; REPRODUCIBILITY OF RESULTS;

EID: 83155192725     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03389.x     Document Type: Article

References (18)

1. Association of Public Health Observatories. APHO Diabetes Prevalence Model: Key Findings for England. York: Yorkshire and Humber Public Health Observatory, 2010.
2. Holman NF, Forouhi NG, Goyder E, Wild SH. The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabet Med 2011; 28: 575-582.
3. Health Survey for England. Health Survey for England 2006. London: The Information Centre, 2008.
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-S69.
5. Mostafa SA, Davies MJ, Webb D, Gray LJ, Srinivasan BT, Jarvis J et al. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type2 diabetes mellitus. Diabet Med 2010; 27: 762-769.
6. Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among US adults. Diabetes Care 2010; 33: 95-97.
7. Lorenzo C, Haffner SM. Performance characteristics of the new definition of diabetes: The Insulin Resistance Atherosclerosis Study. Diabetes Care 2010; 33: 335-337.
8. Van't Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population: The New Hoorn Study. Diabetes Care 2010; 33: 61-66.
9. National Health Service. The Quality Management and Analysis System. Available at Last accessed 5 April 2011.
10. Ashworth LG, I. Alberti, KG. HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem 1992; 38: 1479-1482.
11. WHO. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization, 2000.
12. WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. Report of a WHO/IDF consultation. Geneva: World Health Organization, 2006.
13. Cochran WG. Sampling Techniques. 3rd edn. New York: Wiley, 1977.
14. National Health Service. Health Survey for England 2004. Updating of Trend Tables to Include 2004 Data. Available at Last accessed 5 April 2011.
15. Goyder EC. Screening for and prevention of type 2 diabetes. BMJ 2008; 336: 1140-1141.
16. US Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: US preventive services task force recommendation statement. Ann Intern Med 2008; 148: 846-854.
17. Wareham NJ, Griffin SJ. Should we screen for type2 diabetes? Evaluation against National Screening Committee criteria. Br Med J 2001; 322: 986-988.
18. Waugh N, Scotland G, McNamee P, Gillet M, Brennan A, Goyder E et al. Screening for type2 diabetes: literature review and economic modeling. Health Technol Assess 2007; 11: 1-144.